Literature DB >> 18723586

Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents.

M Maeng1, L O Jensen, E Falk, H R Andersen, L Thuesen.   

Abstract

OBJECTIVE: We sought to assess vascular remodelling and neointima formation after implantation of bioabsorbable magnesium alloy stents (AMS).
DESIGN: Randomised experimental study.
INTERVENTIONS: AMS (n = 11), sirolimus-eluting stents (Cypher; n = 11) and bare-metal stents (BMS; n = 9) were randomly implanted in 31 porcine coronary arteries (n = 11 pigs). MAIN OUTCOME MEASURES: Neointima formation was measured by histomorphometry at 90 days. Vascular remodelling defined as change in external elastic membrane area from index intervention to follow-up was assessed by serial intravascular ultrasound (IVUS).
RESULTS: By histomorphometry, lumen (median (quartiles); AMS: 1.75 mm2 (1.07-3.26), Cypher 2.52 mm2 (2.22-5.01), BMS 4.55 mm2 (3.2-7.44); p = 0.013) and external elastic membrane area (AMS: 5.56 mm2 (4.09-6.95), Cypher 7.95 mm2 (6.45-10.92), BMS 9.08 mm2 (7.85-11.63); p = 0.014) were smallest after AMS implantation. By IVUS, external elastic membrane area at follow-up was smallest (AMS: 7.5 (2.8) mm2, Cypher 9.1 (2.7) mm2, BMS 9.9 (3.1) mm2; p = 0.33) and change in external elastic membrane area from index intervention to follow-up (remodelling; AMS: -1.0 (3.1) mm2, Cypher 1.0 (0.8) mm2, BMS 0.9 (1.2) mm2; p = 0.30) was greatest in the AMS group. In a dichotomised IVUS assessment of vascular remodelling, six AMS stents were remodelled (negative remodelling: n = 5; positive remodelling: n = 1) at 90-day follow-up (AMS versus Cypher + BMS: p = 0.001). Neointima formation was smallest in the AMS group (p<0.05 for both histomorphometry and IVUS).
CONCLUSION: Coronary implantation of absorbable magnesium stents, compared to two non-absorbable stents, was associated with the smallest lumen area at three-month follow-up because of negative vascular remodelling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723586     DOI: 10.1136/hrt.2007.139261

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Biodegradable Magnesium Alloys: A Review of Material Development and Applications.

Authors:  Dharam Persaud-Sharma; Anthony McGoron
Journal:  J Biomim Biomater Tissue Eng       Date:  2012-02-03

Review 2.  The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology.

Authors:  Michael J Lipinski; Ricardo O Escarcega; Thibault Lhermusier; Ron Waksman
Journal:  J Cardiovasc Transl Res       Date:  2014-05-07       Impact factor: 4.132

3.  Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.

Authors:  Qimao Feng; Wenbo Jiang; Kun Sun; Kang Sun; Sun Chen; Lijiao Zhao; Ke Dai; Ning Ma
Journal:  J Mater Sci Mater Med       Date:  2011-08-06       Impact factor: 3.896

4.  Intermediate analysis of magnesium alloy covered stent for a lateral aneurysm model in the rabbit common carotid artery.

Authors:  Hong-Kai Cui; Fen-Bao Li; Ying-Chang Guo; Yong-Li Zhao; Rui-Fang Yan; Wu Wang; Yong-Dong Li; Yong-Li Wang; Guang-Yin Yuan
Journal:  Eur Radiol       Date:  2017-01-26       Impact factor: 5.315

5.  In vivo response of AZ31 alloy as biliary stents: a 6 months evaluation in rabbits.

Authors:  Yang Liu; Shengmin Zheng; Nan Li; Huahu Guo; Yufeng Zheng; Jirun Peng
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 6.  Cardiovascular Stents: A Review of Past, Current, and Emerging Devices.

Authors:  Alexandru Scafa Udriște; Adelina-Gabriela Niculescu; Alexandru Mihai Grumezescu; Elisabeta Bădilă
Journal:  Materials (Basel)       Date:  2021-05-12       Impact factor: 3.623

7.  Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry.

Authors:  Michael Maeng; Lisette Okkels Jensen; Anne Kaltoft; Hans-Henrik Tilsted; Evald Høj Christiansen; Per Thayssen; Morten Madsen; Henrik Toft Sørensen; Jens Flensted Lassen; Leif Thuesen
Journal:  BMC Cardiovasc Disord       Date:  2012-10-02       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.